New hope for cancer survivors: personalized relief from menopause symptoms
NCT ID NCT07420647
First seen Feb 25, 2026 · Last updated May 23, 2026 · Updated 13 times
Summary
This study tests a personalized, non-hormonal approach to treat genitourinary syndrome of menopause (GSM) in 65 women who have completed cancer treatment. GSM causes vaginal dryness, pain, and urinary discomfort. The goal is to see if tailored treatments can ease these symptoms and improve quality of life and sexual function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENOPAUSE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.